Strategy | Financing Transactions Private Placement / Financing Transactions Procyrion: The company raised $57.7 million in a Series E funding round, including the conversion of $10.0 million of interim financing, on February 5, 2024. The deal was led by Fannin...
Strategy | Financing Transactions Private Placement / Financing Transactions Freenome: The company raised $254 million of venture funding in a deal led by Roche Venture Fund on February 15, 2024, putting the company’s pre-money valuation at $1.95 billion. Bain...
Strategy | Financing Transactions Private Placement / Financing Transactions Neurona Therapeutics: The company raised $120 million of Series E venture funding in a deal led by Viking Global Investors and Cormorant Asset Management on February 8, 2024, putting the...
Strategy | Financing Transactions Private Placement / Financing Transactions Cellanome: The company raised $150 million of Series B venture funding from Premji Invest (US) and undisclosed investors on January 29, 2024, putting the company’s pre-money valuation...
Strategy | Financing Transactions Private Placement / Financing Transactions Synnovation Therapeutics: The company raised $102 million of Series A venture funding in a deal led by Third Rock Ventures on January 24, 2024, putting the company’s pre-money valuation...
Strategy | Financing Transactions Private Placement / Financing Transactions ClevelandDx: The company raised $75 million through a combination of debt, Series E1 and Series E2 venture funding in a deal led by Novo Holdings on January 17, 2024, putting the...
